Loading…
A drug resistance determinant in Trypanosoma brucei
Resistance to antimicrobial agents is undermining the treatment of infectious diseases. Elucidation of the mechanisms determining this resistance would help us understand how drugs can be selectively toxic and also give insight into methods of circumvention. African trypanosomiasis (sleeping sicknes...
Saved in:
Published in: | Trends in microbiology (Regular ed.) 1999-12, Vol.7 (12), p.469-471 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Resistance to antimicrobial agents is undermining the treatment of infectious diseases. Elucidation of the mechanisms determining this resistance would help us understand how drugs can be selectively toxic and also give insight into methods of circumvention. African trypanosomiasis (sleeping sickness), which is caused by a subspecies of the parasitic protozoan Trypanosoma brucei, is resurgent in Africa. A T. brucei clone selected for resistance to an arsenical, sodium melarsen, had no detectable P2 transport activity, whereas a Trypanosoma equiperdum cell line selected for resistance to berenil retained P2 transport activity, although its affinity for the substrate was markedly reduced. T. brucei possess a plethora of purine transporters and salvage enzymes and, therefore, loss of P2 transport has no detectable impact on parasite viability. |
---|---|
ISSN: | 0966-842X 1878-4380 |
DOI: | 10.1016/S0966-842X(99)01643-1 |